A Study of Vitamin D Supplementation on the 90 Days Outcome in Acute Ischemic Stroke Patients and Its Correlation with Vitamin D Levels

This study is a randomized, open-label, parallel control group, single-center, interventional trial evaluating the role of 60,000 IU Vitamin D weekly once supplementation on the 90-day outcome in 86 patients diagnosed with new onset acute ischemic stroke, with Vitamin D deficiency or insufficiency, that will be conducted in a single center in India. The primary outcome measures will be all-cause mortality at 90 days and a Modified Rankin’s Score at admission and 90 days post-rehabilitation. The secondary outcome will be an incidence of recurrent stroke amongst all the study arms.